Univest
Univest
  • Markets
  • Drug Manufacturing Stocks Rally Up to 89% in Six Months: Laurus Labs, Gland Pharma, Divi’s Laboratories and Piramal Pharma as Nifty Pharma Hits a Record on 9 November 2026

    • November 13, 2026
    • Posted by: Neeraj Pandey
    • Category: News
    No Comments
    Drug Manufacturing Stocks Rally Up to 89% in Six Months: Laurus Labs, Gland Pharma, Divi's Laboratories and Piramal Pharma as Nifty Pharma Hits a Record on 9 November 2026

    Drug manufacturing stocks such as Laurus Labs, Gland Pharma and Divi’s have risen up to 89% in six months as Nifty Pharma hit a record. Data, drivers and risks.

    read more
  • Acutaas Chemicals Shares Jump 13% to a Record High After Q2 Profit Rises 71%, Up About 580% in 5 Years: Guidance, Valuation and Risks

    • October 27, 2026
    • Posted by: Ankit Jaiswal
    • Category: News
    No Comments
    Acutaas Chemicals Shares Jump 13% to a Record High After Q2 Profit Rises 71%, Up About 580% in 5 Years: Guidance, Valuation and Risks

    Acutaas Chemicals shares jumped 13% to a record high after Q2 profit rose 71%. See Q2 numbers, raised guidance, valuation, technical levels and risks before you decide.

    read more
  • 3 CDMO Stocks With a Strong Future Roadmap: Divi’s Laboratories, Laurus Labs and Neuland Laboratories

    • October 6, 2026
    • Posted by: Ankit Jaiswal
    • Category: Best Stocks
    No Comments
    3 CDMO Stocks With a Strong Future Roadmap: Divi's Laboratories, Laurus Labs and Neuland Laboratories

    Divi’s Laboratories, Laurus Labs and Neuland Laboratories compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.

    read more